PBYI compared with EBS: revenue, margins and what each company keeps, and the suppliers and customers both name

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

EBSEmergent BioSolutions Inc.

Mkt capRevenueRevenue

Compare

PBYIPuma Biotechnology, Inc.

EBSEmergent BioSolutions Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PBYI 18

PFEPfizersupplier

CVSCVScustomer

MCKMcKessoncustomer

CAHCardinal Healthcustomer

14 more · PBYI chain ›

Shared 0

No shared counterparties.

Only EBS 14

MGNXMacrogenicssupplier

SABSSAB Biotherapeuticscustomer

—Hikma Pharmaceuticalsunlistedsupplier

—Barda

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

10 more · EBS chain ›

PBYIPuma Biotechnology, Inc.

10.57▼−1.12%

Mkt cap$551.8MRevenue$57MQ2 FY26Revenue$228MFY25

EBSEmergent BioSolutions Inc.

5.97▲+1.24%

Regular sessionNov 5 '26

Mkt cap$303.3MRevenue$110MQ3 FY26Revenue$743MFY25

Compare

Regular sessionNov 5 '26

PBYIPuma Biotechnology, Inc.

EBSEmergent BioSolutions Inc.

10.57▼−1.12%

Price

5.97▲+1.24%

$551.8M

Mkt cap

$303.3M

Q2 FY26$57M

Revenue

$110MQ3 FY26

FY25$228M

Revenue

$743MFY25

PBYI10.57▼−1.12%vsEBS5.97▲+1.24%Regular sessionNov 5 '26